Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Giulio Meleleo, PhD
Wolfram Research, Inc.
Disclosure(s): Merck & Co., Inc.: Vendor
Poster(s):
(P-11) Assessing the Epidemiological Impact of an Age-Based Pneumococcal Vaccine Recommendation in France
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-12) Evaluating the Epidemiological Impact of Lowering the Recommended Age for Adult Pneumococcal Vaccination in the United States
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-52) Modeling the Epidemiological Impact of Different Adult Vaccination Strategies in the United Kingdom
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-58) Quantifying the impact of introducing a new adult-focused PCV in the United States
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-617) Estimating Pediatric Breakthrough Disease from Pneumococcal Vaccines in France
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
